On January 7, 2016, Chen, Wei; Yan, Shunqi; Loury, David J.; Frye, Leah Lynn; Greenwood, Jeremy Robert; Shelley, Mee Yoo; Wang, Longcheng published a patent.Application In Synthesis of N-(3-Aminophenyl)acrylamide The title of the patent was Inhibitors of bruton’s tyrosine kinase. And the patent contained the following:
Disclosed herein are compounds that form covalent bonds with Bruton’s tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. In addition, reversible inhibitors of Btk are also described. Also disclosed are pharmaceutical compositions that include the compounds Methods of using the Btk inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions. The experimental process involved the reaction of N-(3-Aminophenyl)acrylamide(cas: 16230-24-3).Application In Synthesis of N-(3-Aminophenyl)acrylamide
The Article related to purine preparation bruton tyrosine kinase inhibitor autoimmune disease cancer, Heterocyclic Compounds (More Than One Hetero Atom): Pyrimidines and Quinazolines and other aspects.Application In Synthesis of N-(3-Aminophenyl)acrylamide
Referemce:
Amide – Wikipedia,
Amide – an overview | ScienceDirect Topics